☆ 4.6 Article

Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening

PHARMACEUTICALS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Medicinal

Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease

Joonhong Jun et al.

Summary: Despite numerous efforts, developing effective treatments for Alzheimer's disease is difficult due to the lack of a clear target. This study reveals JNK3 as a potential target protein for AD treatment, as it is specifically expressed in the brain and involved in neuronal apoptosis.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

添加到收藏夹

Article Chemistry, Medicinal

Carbamate JNK3 Inhibitors Show Promise as Effective Treatments for Alzheimer?s Disease: In Vivo Studies on Mouse Models

Joonhong Jun et al.

Summary: We have developed new inhibitors for c-Jun N-terminal kinase 3 (JNK3) as a potential treatment for Alzheimer's disease (AD). Through pharmacodynamic optimization studies, we identified benzimidazole compounds 2 and 3 as potential JNK3 inhibitors, but their unreliable pharmacokinetic properties led us to develop carbamate inhibitors 2h and 3h. In vitro studies validated carbamate inhibitors 2h and 3h as potent and highly selective JNK3 inhibitors with favorable pharmacokinetic profiles. Oral administration of 2h and 3h improved cognitive function in AD mouse models, indicating their potential as effective treatments for Alzheimer's disease. Carbamate JNK3 inhibitor 3h, in particular, restored cognitive function and reduced pTau levels in the hippocampal tissues of AD mice.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

添加到收藏夹

Article Chemistry, Medicinal

Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases

Yumeng Zhu et al.

Summary: This article introduces the JNK signaling pathways and different chemical types of JNK inhibitors, focusing on their structure-activity relationships and biological activities. The challenges and strategies for the development of JNK inhibitors are also discussed. It provides valuable references for the development of novel selective JNK inhibitors.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Design, synthesis and biological evaluation of novel O-substituted tryptanthrin oxime derivatives as c-Jun N-terminal kinase inhibitors

Igor A. Schepetkin et al.

Summary: This study synthesized a panel of novel tryptanthrin oxime analogs and evaluated their binding affinity to JNK1-3 and inhibition of cellular inflammatory responses. Compound 1j exhibited high binding affinity to JNK1-3 and demonstrated anti-inflammatory activity by inhibiting the production of multiple proinflammatory cytokines. Molecular modeling confirmed the binding mode of 1j to JNK3.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB/IL-6/STAT3 and JNK/PTX3 pathways

Wan Li et al.

Summary: This study identified sphingosine kinase 1 (SPHK1) as an up-regulated gene in glioblastoma (GBM) patients, and demonstrated its association with poor prognosis and reduced overall survival. Overexpression of SPHK1 promoted the proliferation, invasion, metastasis, and clonogenicity of GBM cells, while silencing SPHK1 had the opposite effect. SPHK1 promoted inflammation and proliferation of GBM cells through the NF-KB/IL-6/STAT3 and JNK signaling pathways, and formed a positive feedback loop with PTX3 to enhance GBM growth. Inhibition of SPHK1 by the inhibitor PF543 decreased tumorigenesis in GBM mouse models.

ACTA PHARMACEUTICA SINICA B (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Fragment-Based and Structural Investigation for Discovery of JNK3 Inhibitors

Men Thi Hoai Duong et al.

Summary: This study utilized virtual fragment screening, STD NMR, in vitro kinase assay, and X-ray crystallography to identify 27 initial hits targeting JNK3 and demonstrating activity inhibition. The structures of JNK3 with a fragment and a potent inhibitor were determined by X-ray crystallography, revealing a common JNK3-binding feature.

PHARMACEUTICS (2022)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of the c-Jun N-Terminal Kinase Inhibitor CC-90001

Mark A. Nagy et al.

Summary: A novel series of JNK inhibitors with increased JNK1 bias have been identified through synthesis and SAR studies, showing low nanomolar JNK inhibitory potency, overall kinome selectivity, and the ability to inhibit cellular phosphorylation of the direct JNK substrate c-Jun. Physiochemical optimization in this series led to compounds with excellent systemic exposure post oral dosing, leading to the selection of a clinical development candidate, CC-90001, currently in Phase II trials for patients with idiopathic pulmonary fibrosis.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Identification of Phelligridin-Based Compounds as Novel Human CD73 Inhibitors

Sifan Lyu et al.

Summary: This study identified novel compounds with CD73 inhibitory activity using computer-aided drug discovery and enzymatic-based assays. Compounds based on phelligridin showed the best inhibitory effects and may serve as lead compounds for developing CD73-targeting drugs. The molecular weight of the identified inhibitors is around 500 Daltons, and they are predicted to primarily form hydrogen bonds with CD73, in addition to hydrophobic stacking interactions.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

添加到收藏夹

Article Chemistry, Medicinal

N-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors

Yangbo Feng et al.

Summary: A novel indazole/aza-indazole scaffold was developed as a JNK3 inhibitor, with compound 29 showing potent and selective inhibition against JNK3 and JNK2.

ACS MEDICINAL CHEMISTRY LETTERS (2021)

添加到收藏夹

Article Computer Science, Artificial Intelligence

A geometric deep learning approach to predict binding conformations of bioactive molecules

Oscar Mendez-Lucio et al.

Summary: DeepDock, developed by Mendez-Lucio and colleagues, utilizes geometric deep learning to predict binding conformations of ligands to protein targets, providing guidance for molecular optimization. The method learns a statistical potential based on distance likelihood, tailored for each ligand-target pair, and can reproduce experimental binding conformations effectively. This approach showcases the use of artificial intelligence to enhance structure-based drug design.

NATURE MACHINE INTELLIGENCE (2021)

添加到收藏夹

Article Biochemical Research Methods

Deciphering interaction fingerprints from protein molecular surfaces using geometric deep learning

P. Gainza et al.

NATURE METHODS (2020)

添加到收藏夹

Article Chemistry, Physical

A fast and high-quality charge model for the next generation general AMBER force field

Xibing He et al.

JOURNAL OF CHEMICAL PHYSICS (2020)

添加到收藏夹

Review Cell Biology

Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation

Nina D. Anfinogenova et al.

CELLS (2020)

添加到收藏夹

Article Oncology

Evaluation of Artificial Intelligence in Participating Structure-Based Virtual Screening for Identifying Novel Interleukin-1 Receptor Associated Kinase-1 Inhibitors

Jinxin Che et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Machine Learning Models Combined with Virtual Screening and Molecular Docking to Predict Human Topoisomerase I Inhibitors

Bingke Li et al.

MOLECULES (2019)

添加到收藏夹

Article Chemistry, Medicinal

Tri- and Tetrasubstituted Pyridinylimidazoles as Covalent Inhibitors of c-Jun N-Terminal Kinase 3

Felix Muth et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Article Oncology

JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers

Jos L. J. van der Velden et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2016)

添加到收藏夹

Article Oncology

Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents

Irina A. Vasilevskaya et al.

CLINICAL CANCER RESEARCH (2015)

添加到收藏夹

Article Clinical Neurology

H-3 Receptor Antagonist and JNK-3 Inhibitor: A new therapeutic approach to treat Parkinson’s disease

Nilesh Ambhore et al.

PARKINSONISM & RELATED DISORDERS (2015)

添加到收藏夹

Article Chemistry, Medicinal

Inhibitors of c-Jun N-Terminal Kinases: An Update

Pierre Koch et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

添加到收藏夹

Review Biochemistry & Molecular Biology

Recent Progress in the Design, Study, and Development of c-Jun N-Terminal Kinase Inhibitors as Anticancer Agents

Abdellah Messoussi et al.

CHEMISTRY & BIOLOGY (2014)

添加到收藏夹

Review Chemistry, Medicinal

JNK inhibitors as anti-inflammatory and neuroprotective agents

Piotr P. Graczyk

FUTURE MEDICINAL CHEMISTRY (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

G. Madhavi Sastry et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor

Veronique Plantevin Krenitsky et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

添加到收藏夹

Article Biochemistry & Molecular Biology

Multiple ligand docking by Glide: implications for virtual second-site screening

Marton Vass et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)

添加到收藏夹

Review Neurosciences

JNK3 as a Therapeutic Target for Neurodegenerative Diseases

Xanthi Antoniou et al.

JOURNAL OF ALZHEIMERS DISEASE (2011)

添加到收藏夹

Article Chemistry, Medicinal

Virtual Fragment Docking by Glide: a Validation Study on 190 Protein-Fragment Complexes

Mark Sandor et al.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)

添加到收藏夹

Article Neurosciences

Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin

Gerardo A. Morfini et al.

NATURE NEUROSCIENCE (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

The functional contrariety of JNK

Ann M. Bode et al.

MOLECULAR CARCINOGENESIS (2007)

添加到收藏夹

Article Chemistry, Medicinal

Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes

Richard A. Friesner et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

添加到收藏夹

Article Chemistry, Organic

Designing heterocyclic selective kinase inhibitors: from concept to new drug candidates

Serge Halazy

ARKIVOC (2006)

添加到收藏夹

Article Chemistry, Medicinal

Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

RA Friesner et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

添加到收藏夹

Article Chemistry, Medicinal

Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening

TA Halgren et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

添加到收藏夹

Article Pharmacology & Pharmacy

AS601245 (1,3-benzothiazol-2-yl(2-{[2-(3-pyridinyl)ethyl]amino}-4 pyrimidinyl) acetonitrile):: A c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties

S Carboni et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.